While substantial progress has been made over the past decades in delineating securin's involvement in the regulation of CIN and BC progression, several uncharted areas demand further exploration to fully realize its diagnostic, prognostic, and therapeutic potential. This evidence concerns the gene PTTG1 and breast cancer.